CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members

Nature

Volumn 424, Issue 6950, 2003, Pages 793-796

  Trompouki, Eirini ^a   Hatzivassillou, Eudoxia ^a   Tsichritzis, Theodore ^a   Farmer, Hannah ^b   Ashworth, Alan ^b   Mosialos, George ^a  

^a BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; RNA; SKIN;

CYLINDROMATOSIS;

TUMORS;

CD40 ANTIGEN; CYTOKINE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN CYLD; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CHUK PROTEIN, HUMAN; CYLD PROTEIN, HUMAN; ECTODYSPLASIN RECEPTOR; EDA2R PROTEIN, HUMAN; EDAR PROTEIN, HUMAN; EDAR RECEPTOR; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; XEDAR RECEPTOR;

CANCER; MEDICINE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CYLINDROMA; DOWN REGULATION; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SKIN APPENDAGE; CELL LINE; DRUG ANTAGONISM; GENETICS; METABOLISM; MUTATION; PROTEIN BINDING; RNA INTERFERENCE;

ANTIGENS, CD40; CELL LINE; EDAR RECEPTOR; HUMANS; I-KAPPA B KINASE; MEMBRANE PROTEINS; MUTATION; NF-KAPPA B; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTORS, ECTODYSPLASIN; RECEPTORS, TUMOR NECROSIS FACTOR; RNA INTERFERENCE; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN; XEDAR RECEPTOR;

EID: 0042467558     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01803     Document Type: Article

References (27)

1. Bignell, G. R. et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nature Genet. 25, 160-165 (2000).
2. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81-S96 (2002).
3. Jain, A. et al. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nature Immunol. 2, 223-228 (2001).
4. Wilkinson, K. D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11, 1245-1256 (1997).
5. Headon, D. J. & Overbeek, P. A. Involvement of a novel TNF receptor homologue in hair follicle induction. Nature Genet. 22, 370-374 (1999).
6. Yan, M. et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290, 523-527 (2000).
7. Hatzivassiliou, E. & Mosialos, G. Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front. Biosci. 7, d319-d329 (2002).
8. Nguyen, L. T. et al. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 11, 379-389 (1999).
9. Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015-1024 (1999).
10. Yan, M. et al. Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr. Biol. 12, 409-413 (2002).
11. Naito, A. et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc. Natl Acad. Sci. USA 99, 8766-8771 (2002).
12. Kaye, K. M. et al. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl Acad. Sci. USA 93, 11085-11090 (1996).
13. Schultheiss, U. et al. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J. 20, 5678-5691 (2001).
14. Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
15. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
16. Shi, C. S. & Kehrl, J. H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubcl3-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278, 15429-15434 (2003).
17. McKenna, S. et al. An NMR-based model of the ubiquitin-bound human ubiquitin conjugation complex Mms2-Ubc13. The structural basis for lysine 63 chain catalysis. J. Biol. Chem 278, 13151-13158 (2003).
18. Devin, A. et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429 (2000).
19. Devin, A. et al. The α and β subunits of IκB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell. Biol. 21, 3986-3994 (2001).
20. Zhang, S. Q., Kovalenko, A., Cantarella, G. & Wallach, D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation. Immunity 12, 301-311 (2000).
21. Hu, M. et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041-1054 (2002).
22. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301-310 (2002).
23. Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G. & Bernards, R. Loss of cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801 (2003).
24. Mosialos, G. et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399 (1995).
25. Mitchell, T. & Sugden, B. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69, 2968-2976 (1995).
26. Hatzivassiliou, E., Cardot, P., Zannis, V. I. & Mitsialis, S. A. Ultraspiracle, a Drosophila retinoic X receptor α homologue, can mobilize the human thyroid hormone receptor to transactivate a human promoter. Biochemistry 36, 9221-9231 (1997).
27. Devergne, O. et al. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16, 7098-7108 (1996).